Ranbaxy, Glaxo Bury Hatchet Over Valtrex
In a boost to Ranbaxy Laboratories Ltd., the Indian drug giant has won 180 days of exclusive rights to sell a generic version of GlaxoSmithKline's Valtrex in the United States after...To view the full article, register now.
Already a subscriber? Click here to view full article